Literature DB >> 11159660

Management of gastro-oesophageal reflux disease in general practice.

J Dent1, R Jones, P Kahrilas, N J Talley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11159660      PMCID： PMC1119578          DOI： 10.1136/bmj.322.7282.344

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  27 in total

1.  The endoscopic assessment of esophagitis: a progress report on observer agreement.

Authors:  D Armstrong; J R Bennett; A L Blum; J Dent; F T De Dombal; J P Galmiche; L Lundell; M Margulies; J E Richter; S J Spechler; G N Tytgat; L Wallin
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

2.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology.

Authors:  R E Sampliner
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

Review 3.  Treatment of gastro-oesophageal reflux disease in adults.

Authors:  J P Galmiche; E Letessier; C Scarpignato
Journal:  BMJ       Date:  1998-06-06

4.  The impact of gastroesophageal reflux disease on health-related quality of life.

Authors:  D A Revicki; M Wood; P N Maton; S Sorensen
Journal:  Am J Med       Date:  1998-03       Impact factor: 4.965

Review 5.  Gastroesophageal reflux disease.

Authors:  P J Kahrilas
Journal:  JAMA       Date:  1996-09-25       Impact factor: 56.272

6.  Three- to 4.5-year prospective study of prognostic indicators in gastro-oesophageal reflux disease.

Authors:  N I McDougall; B T Johnston; J S Collins; R J McFarland; A H Love
Journal:  Scand J Gastroenterol       Date:  1998-10       Impact factor: 2.423

Review 7.  Gastro-oesophageal reflux disease.

Authors:  J Dent
Journal:  Digestion       Date:  1998-08       Impact factor: 3.216

8.  Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis.

Authors:  C M Bate; J R Green; A T Axon; G Tildesley; F E Murrays; S M Owen; C Emmas; M D Taylor
Journal:  Aliment Pharmacol Ther       Date:  1998-01       Impact factor: 8.171

Review 9.  Quality of life and cost of therapy in reflux disease.

Authors:  H Glise
Journal:  Scand J Gastroenterol Suppl       Date:  1995

10.  A comparison of five maintenance therapies for reflux esophagitis.

Authors:  S Vigneri; R Termini; G Leandro; S Badalamenti; M Pantalena; V Savarino; F Di Mario; G Battaglia; G S Mela; A Pilotto
Journal:  N Engl J Med       Date:  1995-10-26       Impact factor: 91.245
View more
  18 in total

1.  Gastro-oesophageal reflux disease in general practice. Last year's guidelines are probably biased.

Authors:  Helge L Waldum; Eiliv Brenna
Journal:  BMJ       Date:  2002-02-23

Review 2.  Management of gastro-oesophageal reflux disease: role of proton pump inhibitor test and upper gastro-intestinal endoscopy.

Authors:  M A Bianco; G Rotondano; A Prisco; C Meucci; L Cipolletta
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-10       Impact factor: 2.124

Review 3.  Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors:  Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal:  BMJ       Date:  2003-04-05

4.  Esomeprazole: a review of its use in the management of acid-related disorders in the US.

Authors:  Lesley J Scott; Christopher J Dunn; Gordon Mallarkey; Miriam Sharpe
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Maintenance therapy in gastro-oesophageal reflux disease.

Authors:  Miguel Bixquert
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Heartburn severity does not predict disease severity in patients with erosive esophagitis.

Authors:  M Brian Fennerty; David A Johnson
Journal:  MedGenMed       Date:  2006-04-06

7.  Esophageal striated muscle contractions in patients with gastroesophageal reflux symptoms.

Authors:  Roberto O Dantas; Lilian R O Aprile
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

8.  Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.

Authors:  Peter Wahlqvist; Ola Junghard; Andy Higgins; Jonathan Green
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

9.  Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.

Authors:  Sharon K McCann; Marion K Campbell; Vikki A Entwistle
Journal:  Trials       Date:  2010-03-22       Impact factor: 2.279

Review 10.  Esomeprazole: a review of its use in the management of acid-related disorders.

Authors:  Lesley J Scott; Christopher J Dunn; Gordon Mallarkey; Miriam Sharpe
Journal:  Drugs       Date:  2002       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.